UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025045 |
|---|---|
| Receipt number | R000028765 |
| Scientific Title | Prospective study of I-131 3-iodobenzylguanidine radiotherapy for high-risk neuroblastoma; in accordance with the Japanese Advanced Medical Care B program for the anticancer drug with high medical needs. |
| Date of disclosure of the study information | 2016/12/12 |
| Last modified on | 2019/05/27 13:33:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/11/29 15:00:44 | ||
| 2 | Update | 2016/11/29 17:37:54 | UMIN ID1 |
|
| 3 | Update | 2016/12/01 13:40:47 | UMIN ID2 |
|
| 4 | Update | 2016/12/12 14:29:21 | Date of disclosure of the study information |
|
| 5 | Update | 2017/08/21 16:46:46 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 6 | Update | 2017/08/21 16:55:13 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 7 | Update | 2019/05/27 13:30:43 | Recruitment status Date of IRB Last follow-up date Other related information |
|
| 8 | Update | 2019/05/27 13:33:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2019/05/27 13:33:39 | Number of participants that the trial has enrolled |
